PRTAClinical Trials•businesswire•
Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program
Sentiment:Neutral (40)
Summary
DUBLIN--(BUSINESS WIRE)---- $PRTA #Prothena--Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 27, 2025 by businesswire